Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STX-478 alone and in combination in advanced solid tumors
NL-OMON61008Phase 2Recruiting
- Sponsor
- Scorpion Therapeutics
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tersolisib in breast cancer, gynecological cancer, head and neck squamous cell carcinoma (HNSCC), Nonhematologic neoplasms, sponsored by Scorpion Therapeutics. Started Aug 2025; status: recruiting.
02
Drugs
tersolisib
03
Conditions
breast cancergynecological cancerhead and neck squamous cell carcinoma (HNSCC)Nonhematologic neoplasms
Beyond the preview
Go deeper on NL-OMON61008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON61008.